. Physicians, Dr Achard; Dr Aizpurua; Dr Aubertin; Dr Azalbert

D. Bartolo-;-dr and . Berger, Dr Bibette; Dr Biderman; Dr Blochlaine; Dr Cadart; Dr Casenave; Dr Castera; Dr Causse; Dr Corlieu; Dr Delile; Dr Demasse; Dr Depieds; Dr Dewost; Dr Drosson; Dr Duffez; Dr Faust; Dr Gassmann; Dr Guena; Dr Guillet; Dr Gutenkust; Dr Herouin; Dr Herran; Dr Heitz

D. Lang, Dr Lasalarie; Dr Lavignasse; Dr Magnin; Dr Maire; Dr Margelis; Dr Marre; Dr Mauraycaplanne; Dr Michel; Dr Morel

D. Noss-;-dr-pages-;-dr-paillou-;-dr-partouche-;-dr-petit, L. Carrieri, M. Michel, P. Mora, G. Roux et al., Dr Pouclet Dr Raulin; Dr Regard; Dr Reiller Dr Roch; Dr Rouille; Dr Sananes; Dr Sangare; Dr Truffy; Dr Vergez; Dr Vincent; Dr Wajsbrot. Centre of Methodology and Management, INSERM U912: Protocol, guidelines, training: MP Phone interviews, training Data collection, management and statistical analyses, French agency for the safety of health products (AFSSPAS): N. Richard. French Ministry of Health: A. Herszkowicz, N. Prisse. ASUD association: F. Olivet; AIDES association Centre of evaluation and information on drug dependence (CEIP): J.Arditti. Author details 1

R. 1. Mattick, R. , K. J. Breen, C. Davoli, and M. , Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence, Cochrane Database Syst Rev, issue.2, p.2207, 2008.

L. Michel, P. Roux, J. Cohen, and M. Carrieri, Un observatoire fran??ais du traitement des h??patites C chez les usagers de drogue??: commentaire, Gastroent??rologie Clinique et Biologique, vol.33, issue.1, pp.15-16, 2009.
DOI : 10.1016/j.gcb.2008.11.009

M. Carrieri, L. Amass, G. Lucas, D. Vlahov, A. Wodak et al., Buprenorphine Use: The International Experience, Clinical Infectious Diseases, vol.43, issue.Supplement 4, pp.197-215, 2006.
DOI : 10.1086/508184

J. Emmanuelli and J. Desenclos, Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003, Addiction, vol.91, issue.11, pp.1690-1700, 1996.
DOI : 10.1111/j.1360-0443.2005.01271.x

P. Roux, V. Villes, D. Bry, B. Spire, I. Feroni et al., Buprenorphine sniffing as a response to inadequate care in substituted patients: Results from the Subazur survey in south-eastern France, Addictive Behaviors, vol.33, issue.12, pp.331625-1629, 2008.
DOI : 10.1016/j.addbeh.2008.07.018

G. Vidal-trecan, I. Varescon, N. Nabet, and A. Boissonnas, Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France, Drug and Alcohol Dependence, vol.69, issue.2, pp.175-181, 2003.
DOI : 10.1016/S0376-8716(02)00312-5

M. Gossop, J. Marsden, D. Stewart, and T. Kidd, The National Treatment Outcome Research Study (NTORS): 4-5???year follow-up results, Addiction, vol.309, issue.3, pp.291-303, 2003.
DOI : 10.1046/j.1360-0443.2003.00296.x

R. Hubbard, S. Craddock, and J. Anderson, Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS), Journal of Substance Abuse Treatment, vol.25, issue.3, pp.125-134, 2003.
DOI : 10.1016/S0740-5472(03)00130-2

M. Gossop, J. Marsden, D. Stewart, P. Lehmann, and J. Strang, Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study, Br J Gen Pract, issue.438, pp.4931-4965, 1999.

M. Weinrich and M. Stuart, Provision of Methadone Treatment in Primary Care Medical Practices, JAMA, vol.283, issue.10, pp.1343-1348, 2000.
DOI : 10.1001/jama.283.10.1343

D. Fiellin, O. Connor, P. Chawarski, M. Pakes, J. Pantalon et al., Methadone Maintenance in Primary Care, JAMA, vol.286, issue.14, pp.1724-1731, 2001.
DOI : 10.1001/jama.286.14.1724

E. Strain, G. Bigelow, I. Liebson, and M. Stitzer, Moderate- vs High-Dose Methadone in the Treatment of Opioid Dependence, JAMA, vol.281, issue.11, pp.2811000-1005, 1999.
DOI : 10.1001/jama.281.11.1000

T. Kerr, N. Fairbairn, M. Tyndall, D. Marsh, K. Li et al., Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users, Drug and Alcohol Dependence, vol.87, issue.1, pp.39-45, 2007.
DOI : 10.1016/j.drugalcdep.2006.07.009

D. Sheehan, Y. Lecrubier, K. Sheehan, P. Amorim, J. Janavs et al., The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured http://www.biomedcentral.com/1471-2458/12/488 diagnostic psychiatric interview for DSM-IV and ICD-10, J Clin Psychiatry, pp.5922-5955, 1998.

B. Brands, J. Blake, D. Marsh, B. Sproule, R. Jeyapalan et al., The Impact of Benzodiazepine Use on Methadone Maintenance Treatment Outcomes, Journal of Addictive Diseases, vol.20, issue.3, pp.37-48, 2008.
DOI : 10.1081/JA-120016225

S. Leavitt, Methadone-Drug Interactions. Forum: In Addiction Treatment, 2005.

J. Trafton and A. Ramani, Methadone: A new old drug with promises and pitfalls, Current Pain and Headache Reports, vol.9, issue.1, pp.24-30, 2009.
DOI : 10.1007/s11916-009-0006-0

R. Groves and N. Mathiowetz, A comparison of CATI and non- CATI questionnaires. Vital and health statistics, pp.33-39, 1987.

S. Darke, W. Hall, A. Wodak, N. Heather, and J. Ward, Development and validation of a multidimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index, Addiction, vol.83, issue.5, pp.733-742, 1992.
DOI : 10.1016/0376-8716(90)90049-K

C. Fry and N. Lintzeris, Psychometric properties of the Blood-borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ) Addiction, pp.171-178, 2003.

M. Stoove, C. Fry, and N. Lintzeris, Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): Applications for community-based HCV surveillance, education and prevention, Harm Reduction Journal, vol.5, issue.1, p.12, 2008.
DOI : 10.1186/1477-7517-5-12

D. Lucidarme, P. Foutrein, C. Creusy, G. Forzy, M. Foutrein-comes et al., Prevalence of hepatitis C, B and D markers and histopathological aspects in a group of intravenous drug addicts, Gastroenterol Clin Biol, issue.11, pp.18964-968, 1994.

D. Lucidarme, A. Bruandet, D. Ilef, J. Harbonnier, C. Jacob et al., Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France, Epidemiology and Infection, vol.132, issue.4, pp.699-708, 2004.
DOI : 10.1017/S095026880400247X

R. Fuhrer and F. Rouillon, La version française de l'échelle CES-D. Description and translation of the autoevaluation scale (in French), Psychiatrie et Psychobiologie, vol.4, pp.163-166, 1989.

A. Beck, R. Steer, M. Kovacs, and B. Garrison, Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation, Am J Psychiatry, vol.142, issue.5, pp.559-563, 1985.

J. Roberti, E. Storch, and E. Bravata, Further Psychometric Support for the Sensation Seeking Scale-Form V, Journal of Personality Assessment, vol.46, issue.3, pp.291-292, 2003.
DOI : 10.1037//0022-3514.65.4.757

J. Etter, T. Duc, and T. Perneger, Validity of the Fagerstrom test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers, Addiction, vol.94, issue.2, pp.269-281, 1999.
DOI : 10.1046/j.1360-0443.1999.94226910.x

J. Saunders, O. Aasland, T. Babor, J. De-la-fuente, and M. Grant, Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II, Addiction, vol.i, issue.6, pp.791-804, 1993.
DOI : 10.1111/j.1360-0443.1993.tb02093.x

J. Poundja, D. Fikretoglu, S. Guay, and A. Brunet, Validation of the French Version of the Brief Pain Inventory in Canadian Veterans Suffering from Traumatic Stress, Journal of Pain and Symptom Management, vol.33, issue.6, pp.720-726, 2007.
DOI : 10.1016/j.jpainsymman.2006.09.031

M. Smith, G. Winkel, J. Egert, M. Diaz-wionczek, and K. Duhamel, Patient-Physician Communication in the Context of Persistent Pain: Validation of a Modified Version of the Patients' Perceived Involvement in Care Scale, Journal of Pain and Symptom Management, vol.32, issue.1, pp.71-81, 2006.
DOI : 10.1016/j.jpainsymman.2006.01.007

M. Gossop, The development of a short opiate withdrawal scale (SOWS), Addictive Behaviors, vol.15, issue.5
DOI : 10.1016/0306-4603(90)90036-W

J. Ware, . Jr, M. Kosinski, and S. Keller, A 12-Item Short-Form Health Survey, Medical Care, vol.34, issue.3, pp.220-233, 1996.
DOI : 10.1097/00005650-199603000-00003

R. Kessler, L. Adler, M. Ames, O. Demler, S. Faraone et al., The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population, Psychological Medicine, vol.35, issue.2, pp.245-256, 2005.
DOI : 10.1017/S0033291704002892

B. Smyth, J. Barry, A. Lane, M. Cotter, O. Neill et al., In-patient treatment of opiate dependence: medium-term follow-up outcomes, The British Journal of Psychiatry, vol.187, issue.4, pp.360-365, 2005.
DOI : 10.1192/bjp.187.4.360

I. Maremmani, P. Pani, M. Pacini, and G. Perugi, Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients, Journal of Substance Abuse Treatment, vol.33, issue.1, pp.91-98, 2007.
DOI : 10.1016/j.jsat.2006.11.009

H. Wittchen, S. Apelt, M. Soyka, M. Gastpar, M. Backmund et al., Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: A naturalistic study in 2694 patients, Drug and Alcohol Dependence, vol.95, issue.3, pp.95245-257, 2008.
DOI : 10.1016/j.drugalcdep.2008.01.015

M. Carrieri, C. Leport, C. Protopopescu, J. Cassuto, E. Bouvet et al., Factors Associated With Nonadherence to Highly Active Antiretroviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.41, issue.4, pp.477-485, 2006.
DOI : 10.1097/01.qai.0000186364.27587.0e

C. Protopopescu, F. Marcellin, B. Spire, M. Preau, R. Verdon et al., Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8), Quality of Life Research, vol.3, issue.4, pp.577-591, 2007.
DOI : 10.1007/s11136-006-9151-7

J. Caplehorn and O. Drummer, Mortality associated with New South Wales methadone programs in 1994: lives lost and saved, Med J Aust, vol.170, issue.3, pp.104-109, 1999.

R. Cornish, J. Macleod, J. Strang, P. Vickerman, and M. Hickman, Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database, BMJ, vol.341, issue.oct26 2, p.5475, 2010.
DOI : 10.1136/bmj.c5475

O. Morgan, H. Johnson, C. Rooney, V. Seagroatt, and C. Griffiths, Changes to the daily pattern of methadone-related deaths in England and Wales, 1993-2003, Journal of Public Health, vol.28, issue.4, pp.318-323, 2006.
DOI : 10.1093/pubmed/fdl059

J. Greenwood, Creating a new drug service in Edinburgh., BMJ, vol.300, issue.6724, pp.587-589, 1990.
DOI : 10.1136/bmj.300.6724.587

P. Lawrinson, A. Roche, H. Terao, and P. Le, Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists, Drug and Alcohol Review, vol.27, issue.1, pp.47-53, 2008.
DOI : 10.1080/09595230701710852

J. Sheridan, V. Manning, G. Ridge, S. Mayet, and J. Strang, Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England, Addiction, issue.11, pp.1021824-1830, 1995.